MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
22.2 M |
Marktkapitalisierung |
$ 27.7 M |
EBITDA (LTM) |
$ -132 M |
P/E (LTM) |
-0.4 |
P/S (LTM) |
32.39 |
EPS (LTM) |
-2.88 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Esperion Therapeutics
ESPR
|
$ 3.13 | 0.55 % | $ 651 M | Nasdaq Global Market,SPB | USA |
 |
Exelixis
EXEL
|
$ 48.2 | 8.51 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 2.53 | 2.85 % | $ 70.6 M | Nasdaq Capital Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Galapagos NV
GLPG
|
$ 28.81 | 1.48 % | $ 2.69 B | Nasdaq Global Select Market |  Belgium |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Genmab A/S
GMAB
|
$ 27.95 | 1.5 % | $ 17.2 B | Nasdaq Global Select Market |  Danmark |
 |
Genprex
GNPX
|
$ 0.91 | 2.24 % | $ 849 K | Nasdaq Capital Market | USA |
 |
Grifols, S.A.
GRFS
|
$ 8.4 | 1.63 % | $ 6.83 B | Nasdaq Global Select Market |  Spain |
 |
InflaRx N.V.
IFRX
|
$ 2.51 | 27.16 % | $ 152 M | Nasdaq Global Select Market | Germany |
 |
Ionis Pharmaceuticals
IONS
|
$ 77.0 | 2.33 % | $ 12.3 B | Nasdaq Global Select Market,SPB | USA |
 |
BioNTech SE
BNTX
|
$ 94.64 | -0.9 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Kamada Ltd.
KMDA
|
$ 8.29 | 0.91 % | $ 260 M | Nasdaq Global Select Market |  Israel |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 85.79 | 3.72 % | $ 7.25 B | Nasdaq Global Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 13.58 | 0.97 % | $ 1.8 B | Nasdaq Global Select Market |  Australia |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 231.58 | -0.31 % | $ 4.24 B | Nasdaq Global Select Market,SPB | USA |
 |
INmune Bio
INMB
|
$ 1.54 | - | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Liquidia Corporation
LQDA
|
$ 41.64 | 3.75 % | $ 3.58 B | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 22.58 | 1.03 % | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 107.36 | 1.46 % | $ 5.39 B | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.61 | 26.17 % | $ 1.1 B | Nasdaq Global Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.46 | -1.14 % | $ 5.7 M | NYSE American | Israel |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 24.0 | 2.46 % | $ 3.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 41.6 | 19.64 % | $ 286 B | Nasdaq Global Select Market | France |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |